Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted mice
Authors:
Open Access
- 6 October 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 34789
Abstract
Human papillomavirus (HPV) is an epitheliotropic virus that is the primary causal agent for cervical cancer. Langerhans cells (LC) are skin antigen presenting cells that are reduced in number in HPV-infected skin. The aim of this study was to understand the immune-modulatory effects of HPV16 E7 on LC and on the CD8 T cell response to a skin-expressed antigen. To test this, HPV16 E7 was expressed in mouse skin keratinocytes with the model antigen ovalbumin (Ova). Similar to what is observed in HPV-infected human skin, LC numbers were significantly reduced in E7-expressing mouse skin. This shows that expression of the E7 protein alone is sufficient to mediate LC depletion. Expression of E7 with Ova in keratinocytes strongly suppressed the Ova-specific CD8+ T cell response in the skin draining lymph node. When tested in LC-ablated mice, the CD8 T cell response to skin-expressed Ova in control mice was not affected, nor was the T cell response to Ova restored in E7-expressing skin. These data indicate a role for E7 in regulation of LC homeostasis in the skin and in suppression of antigen specific CD8 T cell expansion, but suggest that these two effects occur independent of each other.Keywords
This publication has 55 references indexed in Scilit:
- HPV - immune response to infection and vaccinationInfectious Agents and Cancer, 2010
- Inflammatory cytokines as a third signal for T cell activationCurrent Opinion in Immunology, 2010
- Langerhans cells and more: langerin‐expressing dendritic cell subsets in the skinImmunological Reviews, 2010
- Epigenetic repression of E-cadherin by human papillomavirus 16 E7 proteinCarcinogenesis, 2010
- CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cellsJournal of Experimental Medicine, 2009
- Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cellsJournal of Experimental Medicine, 2008
- Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic CellsImmunity, 2008
- Identification of a novel population of Langerin+ dendritic cellsJournal of Experimental Medicine, 2007
- The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cellsJournal of Experimental Medicine, 2007
- Langerhans cells cross-present antigen derived from skinProceedings of the National Academy of Sciences, 2006